Sysmex Financial Statements From 2010 to 2026

SSMXF Stock  USD 9.88  0.00  0.00%   
Sysmex's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Sysmex's valuation are provided below:
Sysmex does not presently have any fundamental trend indicators for analysis.
Check Sysmex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sysmex's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sysmex financial statements analysis is a perfect complement when working with Sysmex Valuation or Volatility modules.
  
This module can also supplement various Sysmex Technical models . Check out the analysis of Sysmex Correlation against competitors.

Sysmex Company Return On Equity Analysis

Sysmex's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Sysmex Return On Equity

    
  0.13  
Most of Sysmex's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sysmex is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Sysmex has a Return On Equity of 0.1315. This is 100.55% lower than that of the Healthcare sector and 102.2% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is 142.42% lower than that of the firm.

Sysmex Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Sysmex's current stock value. Our valuation model uses many indicators to compare Sysmex value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sysmex competition to find correlations between indicators driving Sysmex's intrinsic value. More Info.
Sysmex is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.73  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sysmex is roughly  1.38 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sysmex's earnings, one of the primary drivers of an investment's value.

About Sysmex Financial Statements

Sysmex stakeholders use historical fundamental indicators, such as Sysmex's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sysmex investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sysmex's assets and liabilities are reflected in the revenues and expenses on Sysmex's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sysmex. Please read more on our technical analysis and fundamental analysis pages.
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan. SYSMEX CORP operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 8771 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Sysmex Pink Sheet

Sysmex financial ratios help investors to determine whether Sysmex Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sysmex with respect to the benefits of owning Sysmex security.